The purpose of our letter to the editor is to offer additional perspective regarding 4 statements that do not fully represent the totality of the available scientific evidence. The 4 statements are as follows: (1) "Multiple studies have shown that n-3 PUFA products frequently have less n-3 PUFA content than labelled"; (2) "Recently, krill oil supplementation was shown to induce insulin resistance, indicating that it is potentially harmful"; (3) "… fish oil products are frequently oxidized at the time of purchase"; and (4) "In rats, supplementation with oxidized fish oil during pregnancy induced persistent maternal insulin resistance and increased neonatal mortality rate." We respectfully request the authors' future publications consider the totality of the available scientific evidence.
Keywords: DHA; EPA; oil; omega-3 long-chain polyunsaturated fatty acids; quality.
© The Author(s) 2021. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: [email protected].